Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs

This publication has 16 references indexed in Scilit:

• TRAIL: A Potential Agent for Cancer Therapy
  Current Molecular Medicine, 2003
• Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines
  European Journal Of Cancer, 2003
• Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines
  Cancer Letters, 2002
• Targeting death and decoy receptors of the tumour-necrosis factor superfamily
  Nature Reviews Cancer, 2002
• Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs
  European Journal Of Cancer, 2002
• Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer Cells
  Gynecologic Oncology, 2001
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: A rationale for combination therapy with chemotherapeutic agents
  International Journal of Cancer, 1995
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
  Advances in Enzyme Regulation, 1984
• Analysis of combined drug effects: a new look at a very old problem
  Trends in Pharmacological Sciences, 1983